CRYOPORT, INC. Common Stock, Value, Issued
CRYOPORT, INC. (CYRX) had Common Stock, Value, Issued of $51.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:CommonStockValue · last filed 2026-08-06
- 2026-06-30: Common Stock, Value, Issued $51.00K.
- 2026-03-31: Common Stock, Value, Issued $50.00K.
- 2025-12-31: Common Stock, Value, Issued $50.00K.
- 2025-09-30: Common Stock, Value, Issued $50.00K.
| Period end | Common Stock, Value, Issued | Common Stock, Value, Issued as first filed |
|---|---|---|
| 2026-06-30 | $51.00K 10-Q · filed 2026-08-06 | |
| 2026-03-31 | $50.00K 10-Q · filed 2026-05-05 | |
| 2025-12-31 | $50.00K 10-Q · filed 2026-08-06 | |
| 2025-09-30 | $50.00K 10-Q · filed 2025-11-06 | |
| 2025-06-30 | $50.00K 10-Q · filed 2025-08-12 | |
| 2025-03-31 | $50.00K 10-Q · filed 2025-05-08 | |
| 2024-12-31 | $50.00K 10-K · filed 2026-03-05 | |
| 2024-09-30 | $49.00K 10-Q · filed 2024-11-07 | |
| 2024-06-30 | $49.00K 10-Q · filed 2024-08-08 | |
| 2024-03-31 | $49.00K 10-Q · filed 2024-05-08 | |
| 2023-12-31 | $49.00K 10-K · filed 2025-03-07 | |
| 2023-09-30 | $49.00K 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $49.00K 10-Q · filed 2023-08-09 | |
| 2023-03-31 | $48.00K 10-Q · filed 2023-05-04 | |
| 2022-12-31 | $48.00K 10-K · filed 2024-03-13 | |
| 2022-09-30 | $49.00K 10-Q · filed 2022-11-04 | |
| 2022-06-30 | $49.00K 10-Q · filed 2022-08-04 | |
| 2022-03-31 | $50.00K 10-Q · filed 2022-05-05 | |
| 2021-12-31 | $50.00K 10-K · filed 2023-02-28 | |
| 2021-09-30 | $46.00K 10-Q · filed 2021-11-04 | |
| 2021-06-30 | $46.00K 10-Q · filed 2021-08-06 | |
| 2021-03-31 | $45.00K 10-Q · filed 2021-05-06 | |
| 2020-12-31 | $40.00K 10-K · filed 2022-02-28 | |
| 2020-09-30 | $38.98K 10-Q · filed 2020-11-06 | |
| 2020-06-30 | $38.56K 10-Q · filed 2020-08-10 | |
| 2020-03-31 | $37.93K 10-Q · filed 2020-05-08 | |
| 2019-12-31 | $37.00K 10-K · filed 2021-03-01 | $37.34K 10-K · filed 2020-03-10 |
| 2019-09-30 | $35.84K 10-Q · filed 2019-11-12 | |
| 2019-06-30 | $35.49K 10-Q · filed 2019-08-09 | |
| 2019-03-31 | $30.68K 10-Q · filed 2019-05-09 | |
| 2018-12-31 | $30.32K 10-K · filed 2020-03-10 | |
| 2018-09-30 | $29.21K 10-Q · filed 2018-11-08 | |
| 2018-06-30 | $28.45K 10-Q · filed 2018-08-09 | |
| 2018-03-31 | $27.59K 10-Q · filed 2018-05-03 | |
| 2017-12-31 | $25.70K 10-K · filed 2019-03-13 | |
| 2017-09-30 | $25.22K 10-Q · filed 2017-11-02 | |
| 2017-06-30 | $23.99K 10-Q · filed 2017-08-09 | |
| 2017-03-31 | $23.94K 10-Q · filed 2017-05-04 | |
| 2016-12-31 | $17.60K 10-K · filed 2018-03-08 | |
| 2016-09-30 | $15.13K 10-Q · filed 2016-11-14 | |
| 2016-06-30 | $15.12K 10-Q · filed 2016-08-15 | |
| 2016-03-31 | $12.25K 10-KT · filed 2017-03-13 | |
| 2015-12-31 | $7.25K 10-Q · filed 2016-02-11 | |
| 2015-09-30 | $7.17K 10-Q · filed 2015-11-16 | |
| 2015-06-30 | $5.07K 10-Q · filed 2015-08-06 | |
| 2015-03-31 | $5.03K 10-K · filed 2016-06-28 | |
| 2014-12-31 | $60.06K 10-Q · filed 2015-02-05 | |
| 2014-09-30 | $60.06K 10-Q · filed 2014-11-12 | |
| 2014-06-30 | $60.04K 10-Q · filed 2014-07-31 | |
| 2014-03-31 | $5.00K 10-K · filed 2015-05-19 | $59.98K 10-K · filed 2014-06-25 |
| 2013-12-31 | $59.25K 10-Q · filed 2014-02-13 | |
| 2013-09-30 | $58.15K 10-Q · filed 2013-11-18 | |
| 2013-06-30 | $38.26K 10-Q · filed 2013-08-14 | |
| 2013-03-31 | $37.76K 10-K · filed 2014-06-25 | |
| 2012-12-31 | $37.76K 10-Q · filed 2013-02-14 | |
| 2012-09-30 | $37.76K 10-Q · filed 2012-11-09 | |
| 2012-06-30 | $37.76K 10-Q · filed 2012-08-14 | |
| 2012-03-31 | $37.76K 10-K · filed 2013-06-25 | |
| 2011-12-31 | $28.28K 10-Q · filed 2012-02-21 | |
| 2011-09-30 | $28.13K 10-Q · filed 2011-11-14 | |
| 2011-06-30 | $27.71K 10-Q · filed 2011-08-15 | |
| 2011-03-31 | $27.50K 10-K · filed 2012-06-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 | |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |